Hans van Houte
Chief Financial Officer at Nurix Therapeutics · 24 reported transactions in 1 company · latest trade Aug 4, 2026
Their trades
Sold | Aug 4, 2026 | Aug 4, 2026 close $24.69 → Oct 29, 2026 close $27.12. S&P 500 +0.1% over the same days. | ||
Sold | Aug 4, 2026 | Aug 4, 2026 close $24.69 → Oct 29, 2026 close $27.12. S&P 500 +0.1% over the same days. | ||
Sold | Jul 30, 2026 | Jul 30, 2026 close $23.58 → Oct 29, 2026 close $27.12. S&P 500 +4.1% over the same days. | ||
Sold | Jan 30, 2026 | Jan 30, 2026 close $16.52 → Oct 29, 2026 close $27.12. S&P 500 +11.6% over the same days. | ||
Sold | Jan 30, 2026 | Jan 30, 2026 close $16.52 → Oct 29, 2026 close $27.12. S&P 500 +11.6% over the same days. |
$73.1K
Aug 4, 2026 close $24.69 → Oct 29, 2026 close $27.12. S&P 500 +0.1% over the same days.
$42.9K
Aug 4, 2026 close $24.69 → Oct 29, 2026 close $27.12. S&P 500 +0.1% over the same days.
$66.5K
Jul 30, 2026 close $23.58 → Oct 29, 2026 close $27.12. S&P 500 +4.1% over the same days.
$1.3K
Jan 30, 2026 close $16.52 → Oct 29, 2026 close $27.12. S&P 500 +11.6% over the same days.
$59.5K
Jan 30, 2026 close $16.52 → Oct 29, 2026 close $27.12. S&P 500 +11.6% over the same days.